Quanex Building Products Corp

The stock remains in early Stage 1 consolidation after a terminal decline, trading above repaired short-term EMAs and a flattening 50 DMA. Stage classification suggests budding bullish permission with a rising risk of a Stage 2 advance. At range resistance and with price extended above EMAs, short-term conditions are not optimal for immediate entry, favoring a deferred buy on pullbacks into the EMAs or broken resistance zone.

• ↑Q2 2026 revenue grew 2.2% YoY to $462.4M driven by pricing and FX
• ↑Management plans mid-single to low-teens price increases to combat inflation
• ↓Q2 gross margin tumbled 350 bps YoY amid raw material and logistics cost rises